- VernacularTitle:带状疱疹疫苗有效性和安全性研究进展
- Author:
Lu CHEN
1
;
Guohua ZHONG
1
;
Lingxian QIU
1
;
Mengjun LIAO
1
;
Ting WU
1
;
Wei WANG
1
;
Yingying SU
1
Author Information
- Publication Type:Journal Article
- Keywords: Herpes zoster; Vaccine; Effectiveness; Safety; Immunodeficiency
- From: Chinese Journal of Microbiology and Immunology 2025;45(5):420-426
- CountryChina
- Language:Chinese
- Abstract: Herpes zoster (HZ) and its complications remain one of the major public health problems threatening human health. Four HZ vaccines are currently licensed for commercial use worldwide, while novel HZ vaccine candidates based on diverse technological platforms are in different stages of development. Enhancing public understanding of the effectiveness and safety of HZ vaccines is particularly crucial for increasing vaccine coverage and reducing vaccine hesitancy. This article introduces the overview of licensed HZ vaccines with a focus on elucidating the effectiveness and safety of HZ vaccines in immunocompetent and immunocompromised populations, in order to provide a scientific basis for the deployment of HZ vaccination.

